NeoGenomics Reports 122% Revenue Growth to $60.5 Million and 11% Reduction in Average Cost per Test in the Fourth Quarter of 2016
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| NEOGENOMICS (NASDAQ: NEO) | Delayed: 17.04 +0.42 (2.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $16.62 | 52 Week High | $9.54 | |||
| Open | $16.62 | 52 Week Low | $5.49 | |||
| Day High | $17.30 | P/E | 426.00 | |||
| Day Low | $16.54 | EPS | $0.04 | |||
| Volume | 1,493,569 | |||||
